press release RSS



SENTÉ Announces Appointment of Michael Brower as Chief Financial Officer

SAN DIEGO, Nov. 5, 2014 (GLOBE NEWSWIRE) — SENTÉ a specialty aesthetics company pioneering the development of differentiated skincare products based on the science of glycosaminoglycans, today announced the appointment of Michael Brower to Chief Financial Officer. In his new role, Mr. Brower will be responsible for leading strategic finance and operations functions reporting to Michael York, Chief Executive Officer, and will be a key member of the Sente, Inc. executive management team. “Mr. Brower brings to SENTÉ tremendous strategic insight, operational and financial experience in rapidly growing companies,” said Michael York, President and Chief Executive Officer of SENTÉ. “Michael will play a key role as we continue to build our infrastructure, launch new products based on our proprietary formulation...

Continue reading



SENTÉ, Inc. Appoints Randy W. Kriech as Chief Commercial Officer

Aesthetic Industry Leader Brings Nearly Two Decades of Commercial and Marketing Expertise SAN DIEGO, July 22, 2014 (GLOBE NEWSWIRE) — Sente Inc., a privately held specialty aesthetics company pioneering the development of differentiated skincare products based on the science of glycoproteins, today announced the appointment of Randy W. Kriech as chief commercial officer. In his new role, Mr. Kriech will be responsible for leading global marketing, commercial operations and portfolio management. Mr. Kreich will report to Michael York, chief executive officer, and will be a key member of the Sente, Inc. executive management team. “Randy is a respected commercial leader in the aesthetic space and we are thrilled to gain his insight and vision to help guide our company and...

Continue reading



Senté Inc., Appoints Mireille Gillings, Ph.D. to Its Board of Directors

Experienced Biopharmaceutical Industry Executive Adds to the Depth of the Company’s Board SAN DIEGO, June 17, 2014 (GLOBE NEWSWIRE) — Sente Inc., a privately held specialty aesthetics company pioneering the development of differentiated skincare products based on the science of glycoproteins, announced today that it has appointed Mireille Gillings, Ph.D. to its Board of Directors. Dr. Gillings is Sente’s sixth director and brings additional biotechnology industry operations and management experience to the Sente Board of Directors.M Dr. Gillings has more than 20 years experience in the biotechnology industry and is a published academic in the field of neuroscience. In 2004 she founded HUYA Bioscience International and has since grown this privately-held company to become the global leader in accelerating the...

Continue reading



Sente, Inc. Raises $5M in Series C Financing

Capital to Fund Expanded Commercial Operations and Broaden Product Portfolio SAN DIEGO, June 2, 2014 (GLOBE NEWSWIRE) — Sente Inc., a privately held specialty aesthetics company pioneering the development of differentiated skincare products based on the science of glycoproteins, announced today the close of a $5 million Series C financing. The newly raised capital will fund expanded sales and marketing operations to broaden the portfolio of Sente physician dispensed skincare products. The Series C financing, which included both existing and new individual investors, was led by PharmaBio Investments Inc., a Durham, NC based investment firm. “We are very pleased to see a continued strong interest in our company from leading life science investors,” commented Michael York, President and Chief Executive...

Continue reading



Sente, Inc. Announces the Appointment of Michael York as President and Chief Executive Officer

SAN DIEGO, Jul 11, 2013 (GLOBE NEWSWIRE) — Sente, Inc., a privately held cosmeceutical company engaged in the development of differentiated skincare products based on glycoproteins, announced today the appointment of Michael York as President, Chief Executive Officer and a member of the Board of Directors. Mr. York joins Sente after more than 20 years in management and leadership positions at Amylin Pharmaceuticals, Santarus, Inc., Amgen and AstraZeneca. “We are delighted to welcome Mr. York, a well respected commercial leader in the healthcare industry, as President and CEO of Sente. His strategic vision and extensive experience in healthcare operations, marketing and finance, will make him an invaluable member of the Sente team,” said Faheem Hasnain, Chairman of the Board of...

Continue reading